Clinical trial
Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
NCT00579085 is registered in ClinicalTrials.gov with Drexel University College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
- Lead sponsor
- Drexel University College of Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- November 30, 2009
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
complex regional pain syndrome